Search results :

Adefovir dipivoxil

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: J05AF08

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7
Asthenia Asthenia postmarketing — 5% - 13% 14% x x x x x x x
Blood creatinine increased Creatinine increased very common, 7% x x x x x
Serum creatinine increased postmarketing x x x x x x x
Haematuria Haematuria 11% 10% x x x
Abdominal pain Abdominal pain postmarketing — 9% 11% x x x x x x x
Gastrointestinal pain Abdominal pain postmarketing — 9% 11% x x x x x x x
Headache Headache postmarketing — 9% 10% x x x x x x x
Dermatitis Rash postmarketing, common x x x x x x x
Rash Rash postmarketing, common x x x x x x x
Nausea Nausea postmarketing — 5% 8% x x x x x x x
Pruritus Pruritus postmarketing, common x x x x x x x
Vomiting Vomiting postmarketing, common x x x x x x x
Renal impairment Kidney function abnormal postmarketing, common x x x x x x
Renal impairment postmarketing x
Flatulence Flatulence postmarketing — 4% 4% x x x x x x
Diarrhoea Diarrhoea postmarketing — 3% 4% x x x x x x x
Dyspepsia Dyspepsia postmarketing — 3% 2% x x x x x x
Glycosuria Glycosuria 1% 3% x x x
Connective tissue disorder Connective tissue disorder postmarketing x x x x
Fanconi syndrome Fanconi syndrome postmarketing x x x x
Renal tubular disorder Fanconi syndrome postmarketing x x x x
Multiple fractures Fracture postmarketing x x
Fracture Fracture postmarketing x x
Gastrointestinal disorder Gastrointestinal disorder postmarketing x x x
Hepatitis Hepatitis postmarketing x x x x
Liver disorder Liver disorder postmarketing x
Hepatocellular injury Liver disorder postmarketing x
Foetor hepaticus Liver disorder postmarketing x
Myopathy Myopathy postmarketing x x x x
Nervous system disorder Nervous system disorder postmarketing x x x
Osteomalacia Osteomalacia postmarketing x x x x
Pancreatitis Pancreatitis postmarketing x x
Renal failure Renal failure postmarketing, common x x x x x x x
Renal impairment postmarketing x
Urethral disorder Urinary tract disorder postmarketing x x x x x
Urinary tract disorder Urinary tract disorder postmarketing x x x x x
Hypophosphataemia Hypophosphataemia postmarketing, common x x x x x x
Bone pain Bone pain postmarketing x x
Malnutrition Malnutrition postmarketing x x x x
Skin disorder Unspecified disorder of skin and subcutaneous tissue postmarketing x x x
Hepatobiliary disease Hepatobiliary disease postmarketing x
Hepatitis B e antigen positive Hepatitis B e antigen positive postmarketing x
Nephropathy toxic Nephropathy toxic postmarketing x
Nephrotoxicity x x
Anaemia Anaemia x
Decreased appetite Anorexia x
Decreased appetite x
Back pain Back pain x
Chest pain Chest pain x
Cough Cough x
Cough increased x
Body temperature increased Body temperature increased x x
Hyperkalaemia Hyperkalaemia x
Jaundice Jaundice x
Pharyngitis Pharyngitis x x
Sinusitis Sinusitis x x
Thrombocytopenia Thrombocytopenia x
Weight decreased Weight decreased x
Hepatic failure Hepatic failure x x
Hepatic function abnormal Hepatic function abnormal x
Liver function test abnormal Liver function test abnormal x
Alanine aminotransferase increased Alanine aminotransferase increased x
Myalgia Myalgia x
Musculoskeletal discomfort Myalgia x
Blood phosphorus decreased Phosphorus low x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

adefovir dipivoxil / HEPSERA

Side effects:21
Source:FDA

ADEFOVIR DIPIVOXIL / HEPSERA

Side effects:18
Source:FDA

ADEFOVIR DIPIVOXIL / HEPSERA

Side effects:18
Source:FDA

adefovir dipivoxil / Hepsera

Side effects:24
Source:FDA

adefovir dipivoxil / adefovir dipivoxil

Side effects:31
Source:EMA

ADEFOVIR DIPIVOXIL / HEPSERA

Side effects:37
Source:Health Canada

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label